MAHONY SUSAN 1463321 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-10-06 | 2023-10-06 | 2023-10-06 | 4 | Mahony Susan | DIRECTOR | dsp | 9345.0 | 100.0 | 0.41 | 116.5 | Direct | Ordinary Shares | HORIZON THERAPEUTICS PUBLIC LTD CO | code D | 0.0 | 228.99 (HZNP) |
2023-10-06 | 2023-10-06 | 2023-10-06 | 4 | Mahony Susan | DIRECTOR | dsp | 9306.0 | 100.0 | 0.41 | 116.5 | By Trust | Ordinary Shares | HORIZON THERAPEUTICS PUBLIC LTD CO | code D | 0.0 | 228.99 (HZNP) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-05-30 | 2023-05-25 | 2023-05-25 | 4 | Mahony Susan | DIRECTOR | acq | 20000.0 | 100.0 | 3.84 | 0.97 | Direct | Stock Option (Right To Buy) | ASSEMBLY BIOSCIENCES, INC. | code A | 20000.0 | 52.12 (ASMB) |
2023-07-28 | 2023-07-27 | 2023-07-27 | 4 | Mahony Susan | DIRECTOR | acq | 4016.0 | 100.0 | 0.18 | 0.0 | Direct | Restricted Stock Units | HORIZON THERAPEUTICS PUBLIC LTD CO | code A | 4016.0 | 228.62 (HZNP) |
2023-10-06 | 2023-10-06 | 2023-10-06 | 4 | Mahony Susan | DIRECTOR | dsp | 4016.0 | 100.0 | 0.18 | 0.0 | Direct | Restricted Stock Units | HORIZON THERAPEUTICS PUBLIC LTD CO | code D | 0.0 | 228.99 (HZNP) |
2023-10-12 | 2023-10-10 | 2023-10-10 | 4 | Mahony Susan | DIRECTOR | acq | 7375.0 | 100 | 1.56 | 70.56 | Direct | Stock Option (Right To Buy) | AXSOME THERAPEUTICS, INC. | code A | 5873.0 | 47.19 (AXSM) |
2023-12-08 | 2023-12-07 | 2023-12-07 | 4 | Mahony Susan | DIRECTOR | acq | 37000.0 | 100.0 | 5.29 | 9.55 | Direct | Stock Option (Right To Buy) | ZYMEWORKS INC. | code A | 37000.0 | 70.0 (ZYME) |
2024-02-29 | 2024-02-27 | 2024-02-27 | 4 | Mahony Susan | DIRECTOR | acq | 191.0 | 100.0 | 0.04 | 84.0 | Direct | Stock Option (Right To Buy) | AXSOME THERAPEUTICS, INC. | code A | 191.0 | 47.32 (AXSM) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)